The study team reported a Neisseria gonorrhoeae prevalence of 9% by qPCR in a cohort of 117 transgender women (TGW) attending Fundación Huésped in Buenos Aires. Rectal infections dominated the case mix: nine of the ten qPCR-positive results were rectal (8% of participants), one was pharyngeal (1%), and no infections were detected in first-void urine (FVU). These data indicate that urine-based screening alone would have missed all NG infections in this cohort.
Participants had a median age of 32 years (IQR 29–39). The cohort showed marked social and behavioral risk characteristics: 55% had not completed high school, 54% reported current engagement in sex work, 55% reported five or more sexual partners in the prior month, and 68% reported recreational substance use within the previous year. At baseline, 46% were living with HIV and 20% had active syphilis; 6% had extragenital Chlamydia trachomatis. The study team collected these sociodemographic and behavioral variables by questionnaire and presented them as context for the infection findings.
Molecular testing (real-time PCR/qPCR) identified 10 NG-positive participants. Culture recovery, by contrast, lagged: only three of nine PCR-positive rectal samples produced viable isolates on culture. The authors used quantification cycle (Cq) values from qPCR-positive samples as a proxy for bacterial load; 70% of positive PCR samples had a Cq ≥ 28, which the investigators interpreted as suggesting lower bacterial loads in most detected infections. The limited culture yield emphasizes a diagnostic gap: molecular detection increases sensitivity for asymptomatic extragenital infection, while culture remains necessary for phenotypic antimicrobial susceptibility testing but may underperform when bacterial loads are low.
All culture isolates that were recovered were reported as susceptible to ceftriaxone and azithromycin. The isolates demonstrated intermediate susceptibility or resistance to tetracycline. The study team performed NG multi-antigen sequence typing (NG-MAST) on cultured isolates and identified sequence types ST21119, ST8202, and ST21122. The abstract did not include detailed breakpoint criteria, minimum inhibitory concentration values, or the full panel of antimicrobials tested; those methodological specifics were not reported in the source abstract.
Authors examined potential associations between asymptomatic extragenital NG infection and collected sociodemographic or behavioral factors, but they reported no significant associations. The abstract did not present formal statistical measures (for example, odds ratios, confidence intervals, or p-values) in support of that statement; therefore the source did not supply those exact metrics in the abstract summary.
The investigators flagged two operational issues that affect surveillance. First, extragenital sampling identified infections that FVU screening missed, supporting targeted extragenital testing among TGW. Second, the low culture recovery rate—only three culture-positive isolates from nine PCR-positive rectal samples—limits the ability to monitor phenotypic antimicrobial resistance using classical culture-based methods. The abstract did not detail alternative molecular resistance-detection assays or describe specific culture conditions that might improve yield, so recommendations for complementary approaches are necessarily general.
Study limitations reported or evident from the abstract include the absence of detailed microbiologic methodology and breakpoints, lack of reported statistical measures for association testing, and the small number of culture isolates available for susceptibility and molecular typing analyses. The source did not provide additional follow-up outcomes or longitudinal data. Those unanswered questions point to specific surveillance gaps: how to reliably obtain cultures from low-burden extragenital infections, which molecular resistance markers correlate with phenotypic resistance in this setting, and whether targeted screening strategies would change clinical outcomes in this population.